Danaher (DHR) is a publicly traded Healthcare sector company. As of August 19, 2026, DHR trades at $199.40 with a market cap of $142.45B and a P/E ratio of 38.77. DHR moved -0.09% today. Year to date, DHR is -12.82%; over the trailing twelve months it is -4.51%. Its 52-week range spans $160.93 to $258.23. Analyst consensus is strong buy with an average price target of $219.78. Rallies surfaces DHR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks DHR insider trades, Form 4 activity, executive purchases, executive sales, shares, prices, and transaction dates when available.
| Metric | Value |
|---|---|
| Price | $199.40 |
| Market Cap | $142.45B |
| P/E Ratio | 38.77 |
| EPS | $5.19 |
| Dividend Yield | 0.40% |
| 52-Week High | $258.23 |
| 52-Week Low | $160.93 |
| Volume | 2 |
| Avg Volume | 0 |
| Revenue (TTM) | $24.78B |
| Net Income | $3.69B |
| Gross Margin | 58.94% |
20 analysts cover DHR: 0 strong buy, 17 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $219.78.